CRISPR mouse models show EML4-ALK fusion variants alter drug response, suggesting a need for variant-specific treatment.

Herb-based therapies like MORRD offer promising alternatives to antibiotics, combating Streptococcus pyogenes and reducing resistance.

Lonza says it provides services ranging from early phase development to full-scale commercial manufacturing at the St. Petersburg site.

RION officials say the company developed a proprietary biomanufacturing platform enabling scaled production of platelet-derived exosomes. This platform allows for the advancement of RION’s pipeline of ...